Entering text into the input field will update the search result below

(MRK,CRWE, CMP, SRI, MMS) Featured Stock by Stock-PR.com

Apr. 28, 2011 10:09 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2011

<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com&quot; target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg&quot; /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835&quot;></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085&quot;></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup&quot; target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg&quot; width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p> </p>
<p><span style="COLOR: black"><font color="black"><strong><img height="85" alt="mrk" src="pennyomega.com/img/mrk.png&quot; width="250" /></strong> MRK, Merck &amp; Co. Inc.</font></span></p>
<p> </p>
<p>According to the Centers for Disease Control and Prevention, about 170 million people worldwide, and 3.2 million in the U.S., have chronic hepatitis C, a disease that can lead to liver cirrhosis and cancer.</p>
<p>No vaccine exists for the virus, which is commonly spread through needle-sharing and can be transmitted sexually in rare cases.</p>
<p><strong>MRK</strong> is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through its prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, <strong>MRK</strong> works with customers and operate in more than 140 countries to deliver innovative health solutions.</p>
<p> </p>
<p align="center"><a href="www.crwenewswire.com/?p=103631&quot; target="_blank"><img alt="pennyomega.com/img/mrk_highlight2.png&quot; src="pennyomega.com/img/mrk_highlight2.png&quot; /></a></p>
<p> </p>
<p><strong>MRK</strong> reported that <strong>the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously</strong> that the available data support approval of <strong>MRK</strong>’s investigational medicine VICTRELIS (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy.</p>
<p><strong>MRK</strong>’s VICTRELIS is one of a new class of medicines known as HCV protease inhibitors being evaluated by the FDA for the treatment of chronic HCV genotype 1 infection in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.</p>
<p>The committee’s recommendation will be considered by the FDA in its review of the New Drug Application for VICTRELIS. The FDA is not bound by the committee’s guidance, but takes its advice into consideration when reviewing investigational medicines. <strong>MRK</strong> anticipates FDA action on VICTRELIS by mid-May.</p>
<p><strong>MRK</strong> also reported that its Board of Directors has approved additional purchases of up to $5 billion of <strong>MRK</strong>’s common stock for its treasury. The treasury stock purchase has no time limit and will be made over time on the open market, in block transactions or in privately negotiated transactions.</p>
<p>Today's <strong>Merck</strong> is a global healthcare leader working to help the world be well. <strong>Merck</strong> is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.</p>
<p><strong>More about MRK at</strong> <a href="www.merck.com&quot;><strong>merck.com&lt;/strong></a><strong>.</strong></p>
<p>******************************</p>
<p> </p>
<p><span style="COLOR: black"><font color="black"><strong><img style="WIDTH: 156px; HEIGHT: 110px" height="110" alt="crwe black" hspace="0" src="pennyomega.com/img/crwe_black.png&quot; width="156" align="bottom" border="0" /> Crown Equity Holdings Inc. (OTCPK:CRWE)</strong></font></span></p>
<p><br />
<strong>Crown Equity Holdings Inc</strong>. announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.<br />
<br />
With online marketing, everything can be tracked and illustrated in detailed graphs that illustrate traffic growth, leads and sales conversions from your specific search marketing campaigns. Using a traffic analysis tool it is easy to calculate your return on investment (ROI) so you can appreciate the excellent value generated from your online marketing budget. Internet provides enormous opportunities for advertisers, and thus they can end up giving the customer more information about a particular product that they are endorsing.</p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Crown Equity Holdings Inc</strong>., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.<br />
<br />
CRWE also hosts newswire sites on which it publishes information that enable clients to reach targeted audiences worldwide. These sites include CRWENewswire.com, CRWENewswire.de, CRWENewswire.fr and CRWENewswire.pk.<br />
<br />
Please Visit Crown Equity Holdings Inc. website</font> <a href="www.crownequityholdings.com&quot;><font color="black">www.crownequityholdings.com&lt;/font></a><br />
<br />
<font color="black">*************************************************************************************<br />
<br />
<strong>Compass Minerals International Inc. (NYSE:CMP)</strong> presented its service excellence awards to key supply chain providers. Twenty-eight companies from the United States, Canada and the United Kingdom were recognized by Angelo Brisimitzakis, Compass Minerals president and CEO, as companies that consistently provided excellent service, innovation and supply chain solutions.<br />
<br />
Compass Minerals International, Inc., through its subsidiaries, engages in the production and marketing of inorganic mineral products in North America and the United Kingdom. The company operates in two segments, Salt and Specialty Fertilizer.<br />
<br />
****************************************<br />
<br />
<strong>Stoneridge Inc. (NYSE:SRI)</strong> will broadcast its first-quarter 2011 earnings conference call live over the Internet on Friday, May 6, 2011, at 9:00 a.m. Eastern time with President and Chief Executive Officer John Corey and Executive Vice President and Chief Financial Officer George Strickler. This webcast can be accessed through the Company's Web site,</font> <a href="www.stoneridge.com&quot;><font color="black">stoneridge.com&lt;/font></a><font color="black">. The webcast is also being distributed over CCBN's Investor Distribution Network. Individual investors can listen to the webcast at</font> <a href="www.fulldisclosure.com&quot;><font color="black">fulldisclosure.com&lt;/font></a><font color="black">. Institutional investors can access the webcast via CCBN's password-protected event management site, StreetEvents (</font><a href="www.streetevents.com&quot;><font color="black">streetevents.com&lt;/font></a><font color="black">).<br />
<br />
Stoneridge, Inc., together with its subsidiaries, engages in the design and manufacture of engineered electrical and electronic components, modules, and systems for the medium and heavy-duty truck, automotive, agricultural, and off-highway vehicle markets primarily in North America and Europe.<br />
<br />
****************************************<br />
<br />
<strong>MAXIMUS, Inc. (NYSE:MMS)</strong> will issue a press release with its financial results for the three months ended March 31, 2011 at 6:30 a.m. (ET) on Thursday, May 5, 2011, and will host a conference call that same day at 9:00 a.m. (ET). The call can be accessed under the Investor Relations page of the Company's Website at</font> <a href="www.maximus.com&quot;><font color="black">maximus.com&lt;/font></a> <font color="black">or by calling: 877.407.8289 (Domestic)/201.689.8341 (International)<br />
MAXIMUS, Inc. provides operations program management and consulting services to state and local government agencies, federal agencies, and commercial customers primarily in the United States.</font></span></span></span></span></p>
<p> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40&quot; target="_blank"><font color="red">stock-pr.com/disclaimer&lt;/font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font></strong></span></span></p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup&quot; target="_blank">stock-pr.com/signup&lt;/a></p>
<p align="center"><a href="www.crownequityholdings.com&quot; target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg&quot; src="stock-pr.com/img/stock-pr_buscard.jpg&quot; /></a></p>

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.